1. Home
  2. HRTX vs TNGX Comparison

HRTX vs TNGX Comparison

Compare HRTX & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • TNGX
  • Stock Information
  • Founded
  • HRTX 1983
  • TNGX 2014
  • Country
  • HRTX United States
  • TNGX United States
  • Employees
  • HRTX N/A
  • TNGX N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • TNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRTX Health Care
  • TNGX Health Care
  • Exchange
  • HRTX Nasdaq
  • TNGX Nasdaq
  • Market Cap
  • HRTX 270.7M
  • TNGX 317.4M
  • IPO Year
  • HRTX 1987
  • TNGX N/A
  • Fundamental
  • Price
  • HRTX $1.73
  • TNGX $2.36
  • Analyst Decision
  • HRTX Strong Buy
  • TNGX Strong Buy
  • Analyst Count
  • HRTX 3
  • TNGX 8
  • Target Price
  • HRTX $5.67
  • TNGX $13.14
  • AVG Volume (30 Days)
  • HRTX 1.2M
  • TNGX 574.3K
  • Earning Date
  • HRTX 02-27-2025
  • TNGX 03-17-2025
  • Dividend Yield
  • HRTX N/A
  • TNGX N/A
  • EPS Growth
  • HRTX N/A
  • TNGX N/A
  • EPS
  • HRTX N/A
  • TNGX N/A
  • Revenue
  • HRTX $137,737,000.00
  • TNGX $43,383,000.00
  • Revenue This Year
  • HRTX $13.10
  • TNGX $27.73
  • Revenue Next Year
  • HRTX $14.03
  • TNGX N/A
  • P/E Ratio
  • HRTX N/A
  • TNGX N/A
  • Revenue Growth
  • HRTX 12.13
  • TNGX 15.67
  • 52 Week Low
  • HRTX $1.04
  • TNGX $2.35
  • 52 Week High
  • HRTX $3.93
  • TNGX $12.02
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 52.86
  • TNGX 33.13
  • Support Level
  • HRTX $1.63
  • TNGX $2.35
  • Resistance Level
  • HRTX $1.83
  • TNGX $2.51
  • Average True Range (ATR)
  • HRTX 0.10
  • TNGX 0.22
  • MACD
  • HRTX -0.01
  • TNGX -0.04
  • Stochastic Oscillator
  • HRTX 41.94
  • TNGX 0.94

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

Share on Social Networks: